Insider holders · CIK 0001907108
Lexeo Therapeutics, Inc. · LXEO
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Richard Nolan TownsendChief Executive Officer | 374,472 | — | 374,472 | Aug 19, 2026 · 5:00 pm EDT | Form 4 |
| Jose Manuel OteroChief Operating Officer | 136,178 | — | 136,178 | Aug 19, 2026 · 5:00 pm EDT | Form 4 |
| Louis Edward TamayoChief Financial Officer | 92,907 | — | 92,907 | Aug 19, 2026 · 5:00 pm EDT | Form 4 |
| Narinder Pal BhallaChief Medical Officer | 82,194 | — | 82,194 | Jul 1, 2026 · 6:48 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.